Anti-fungal effect of berberine on Candida albicans by microcalorimetry with correspondence analysis

被引:3
|
作者
Zhao Y. [1 ]
Yan D. [1 ]
Wang J. [1 ]
Zhang P. [1 ]
Xiao X. [1 ]
机构
[1] China Military Institute of Chinese Materia Medica, 302 Military Hospital of China
基金
中国国家自然科学基金;
关键词
Anti-fungal activity; Berberine; Correspondence analysis; Microcalorimetry;
D O I
10.1007/s10973-009-0565-7
中图分类号
学科分类号
摘要
Using a LKB-2277 bioactivity monitor, stop-flow mode, the power-time curves of Candida albicans growth at 37 °C affected by berberine were measured. The check experiments were studied based on agar cup method to observe the inhibitory diameter and serial dilution method to determine the minimal inhibitory concentration (MIC) of berberine on C. albicans growth. By analyzing the quantitative thermogenic parameters taken from the power-time curves using correspondence analysis (CA), we could find that berberine at a low concentration (5.0 μg mL-1) began to inhibit the growth of C. albicans and at a high concentration (75.0 μg mL-1) completely inhibited C. albicans growth. The anti-fungal activity of berberine could also be expressed as half-inhibitory concentration IC50, i.e., 50% effective in this inhibition. The value of IC50 of berberine on C. albicans was 34.52 μg mL-1. The inhibitory diameters all exceeded 10 mm in test range and the MIC was 500 μg mL-1. Berberine had strong anti-fungal effect on C. albicans growth. This work provided an important idea of the combination of microcalorimetry and CA for the study on anti-fungal effect of berberine and other compounds. Compared with the agar cup method and serial dilution method, microcalorimetry not only offered a useful way for evaluating the bioactivity of drugs, but also provides more information about the microbial growth and all this information was significant for the synthesis and searching of antibiotics. © 2009 Akadémiai Kiadó, Budapest, Hungary.
引用
收藏
页码:49 / 55
页数:6
相关论文
共 50 条
  • [21] Pleurotus sajor-caju can be used to synthesize silver nanoparticles with anti-fungal activity against Candida albicans
    Sandai, D.
    Tabana, Y.
    Musa, F.
    MEDICAL MYCOLOGY, 2018, 56 : S35 - S35
  • [22] Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans
    Bacher, Petra
    Hohnstein, Thordis
    Beerbaum, Eva
    Roecker, Marie
    Blango, Matthew G.
    Kaufmann, Svenja
    Roehmel, Jobst
    Eschenhagen, Patience
    Grehn, Claudia
    Seidel, Kathrin
    Rickerts, Volker
    Lozza, Laura
    Stervbo, Ulrik
    Nienen, Mikalai
    Babel, Nina
    Milleck, Julia
    Assenmacher, Mario
    Cornely, Oliver A.
    Ziegler, Maren
    Wisplinghoff, Hilmar
    Heine, Guido
    Worm, Margitta
    Siegmund, Britta
    Maul, Jochen
    Creutz, Petra
    Tabeling, Christoph
    Ruwwe-Gloesenkamp, Christoph
    Sander, Leif E.
    Knosalla, Christoph
    Brunke, Sascha
    Hube, Bernhard
    Kniemeyer, Olaf
    Brakhage, Axel A.
    Schwarz, Carsten
    Scheffold, Alexander
    CELL, 2019, 176 (06) : 1340 - +
  • [23] Novel synthetic anti-fungal tripeptide effective against Candida krusei
    Gill, K.
    Kumar, S.
    Xess, I.
    Dey, S.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 33 (01) : 110 - 116
  • [24] Anti-fungal effects of slightly acidic electrolyzed water on Candida species
    Wu, Chia-Hsin
    Kaneyasu, Yoshino
    Yano, Kanako
    Shigeishi, Hideo
    Kitasaki, Honami
    Maehara, Tomoko
    Niitani, Yoshie
    Takemoto, Toshinobu
    Mine, Yuichi
    Le, Mi Nguyen-Tra
    Kawada-Matsuo, Miki
    Komatsuzawa, Hitoshi
    Ohta, Kouji
    JOURNAL OF ORAL BIOSCIENCES, 2025, 67 (01)
  • [25] Systemic modulation of human anti-fungal Th17 responses by Candida albicans via cross-reactive T cells
    Bacher, P.
    Roecker, M.
    Thoen, M.
    Nienen, M.
    Stervbo, U.
    Babel, N.
    Hohnstein, T.
    Milleck, J.
    Assenmacher, M.
    Worm, M.
    Creutz, P.
    Ruwwe-Gloesenkamp, C.
    Cornely, O.
    Brandt, C.
    Roehmel, J.
    Schwarz, C.
    Kniemeyer, O.
    Brakhage, A. A.
    Scheffold, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 14 - 14
  • [26] Anti-fungal Effects and Mechanisms of Action of Wasp Venom-Derived Peptide Mastoparan-VT1 Against Candida albicans
    Mojtaba Memariani
    Hamed Memariani
    Zahra Poursafavi
    Zohre Baseri
    International Journal of Peptide Research and Therapeutics, 28
  • [27] Emerging Virulence, Drug Resistance and Future Anti-fungal Drugs for Candida Pathogens
    Srivastava, Vartika
    Singla, Rajeev Kumar
    Dubey, Ashok Kumar
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (09) : 759 - 778
  • [28] Anti-fungal Effects and Mechanisms of Action of Wasp Venom-Derived Peptide Mastoparan-VT1 Against Candida albicans
    Memariani, Mojtaba
    Memariani, Hamed
    Poursafavi, Zahra
    Baseri, Zohre
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2022, 28 (03)
  • [30] CANDIDA BLOODSTREAM INFECTIONS AND ANTI-FUNGAL THERAPY IN ICU PATIENTS: ANALYSIS OF THE EPIC II STUDY POPULATION
    Kett, Daniel
    Azoulay, Elie
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A38 - A38